Biotechnology company Gilead Sciences Inc. (GILD) said Tuesday its board of directors approved plans to repurchase up to $5 billion of the company’s common stock through May 2013. “Gilead’s Board of Directors and senior management team believe that the stock repurchase program announced today represents an appropriate and [...]